Paradigm Medical Announces Promotions in Management Team

SALT LAKE CITY, UT--(Marketwire - May 24, 2010) -

Paradigm Medical Industries, Inc. (PINKSHEETS: PDMI) President and Chief Executive Officer Stephen Davis announced today the following promotions to the Company’s management team: Julio Maximo has been named as Vice President of Operations. Mr. Maximo has over 10 years of engineering experience with Paradigm and was formerly the Director of Operations. Songyun You has been promoted to Manager of Finance. Ms. You has served the Company in the accounting department for six years and was formerly the accounting department manager. Jacob Matthews has been promoted to Manager of Marketing. Mr. Matthews has been with the Company for over two and a half years and formerly served as Sales Administrator and, more recently, as Sales and Marketing Coordinator.

Mr. Davis also announced that Jose Angelo has been named Information Technology Manager and International Sales Representative for South American countries. Mr. Angelo has been with Paradigm for over a year and previously worked in the same capacity for Medtronic Functional Diagnostics. Patrick Davis has been named Service Department Manager. Mr. Davis previously worked in sales and as a software applications engineer in the robotics industry. Angela Velasquez has been promoted to Sales Administrator. Ms. Velasquez joined Paradigm recently as a receptionist and administrative assistant.

“These promotions represent the nucleus of a growing team that will initiate development, implementation and expansion of the growth objectives that will drive Paradigm successfully into the future. Each of these talented individuals has exhibited the foresight, leadership and tenacity to recognize and overcome the obstacles and challenges that face Paradigm in the current marketplace,” said Mr. Davis.

About Paradigm Medical Industries, Inc.

Paradigm Medical Industries, Inc. is a medical device company that develops, manufactures and distributes ophthalmic diagnostic instruments and related products for early detection of glaucoma and other eye disorders. The Company’s primary objective is to capture a niche market within the glaucoma and ultrasound microscopy fields. The Company markets its products to ophthalmologists, optometrists, universities, and clinics throughout the United States and internationally.

This press release contains statements that, if not verifiable historic fact, may be viewed as forward-looking statements that could predict future events and outcomes with respect to Paradigm and its business. The predictions embodied in these statements will involve risk and uncertainties and, accordingly, actual results may differ significantly from the results discussed or implied in such forward-looking statements.